Back

Guideline-adherent antithrombotic treatment improves outcomes in patients with atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 7 - Outcomes in atrial fibrillation Primary cardiovascular prevention: interventions and outcomes ESC Premium Access ESC Congress 2016

About the speaker

Photo
Associate Professor Michal Mazurek

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)

18 More presentations in this session

Presentation thumbnail
Characteristics and outcomes in elderly Japanese and British patients with atrial fibrillation: Comparative analysis from the Fushimi and Darlington Atrial Fibrillation Registries
Doctor H. Ogawa (Moriguchi, JP)
Abstract
Presentation thumbnail
CHA2DS2VASC score is predictive of mortality in patients undergoing coronary angiography
Doctor N. Teodorovich (Rehovot, IL)
Abstract Slides
Presentation thumbnail
Evaluation of the HAS-BLED and ORBIT bleeding risk scores in anticoagulated atrial fibrillation patients receiving oral anticoagulation: data from two different clinical scenarios.
Doctor M. Esteve Pastor (Murcia, ES)
Abstract
Presentation thumbnail
Usefulness of combined SYNTAX and ATRIA score for predicting major bleeding in patients with atrial fibrillation undergoing percutaneous coronary intervention
Doctor Y. Iwasaki (Osaka, JP)
Abstract Slides
Presentation thumbnail
Clinical usefulness of ORBIT score to predict cardiovascular outcomes in patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting
Doctor Y. Iwasaki (Osaka, JP)
Abstract Slides

Access the full session

Session thumbnail
Poster session 7 - Outcomes in atrial fibrillation

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources